Home › Research › Long-term cohort studies
High Blood Pressure and Risk of Dementia: A Two-Sample Mendelian Randomization Study in the UK Biobank
Sproviero W, Winchester L, Newby D, Fernandes M, Shi L, Goodday SM, Prats-Uribe A, Alhambra DP et al.. Biological psychiatry, 2020-12-27
Topic: Risk, prevention and care in population studies
Plain-language summary
Background Findings from randomized controlled trials have yielded conflicting results on the association between blood pressure (BP) and dementia traits. We tested the hypothesis that a causal relationship exists between systolic BP (SBP) and/or diastolic BP (DBP) and risk of Alzheimer's disease (AD). Methods We performed a generalized summary Mendelian randomization (GSMR) analysis using summary statistics of a genome-wide association study meta-analysis of 299,024 individuals of SBP or DBP as exposure variables against three different outcomes: 1) AD diagnosis (International Genomics of Alzheimer's Project), 2) maternal family history of AD (UK Biobank), and 3) paternal family history of AD (UK Biobank).
What this study adds
Evidence grade: High
This is a pooled review of 299,024 participants. This genetic analysis tested whether blood pressure has a causal relationship with Alzheimer's disease risk. It is a Mendelian randomization study and does not show that lowering blood pressure treats, cures, or prevents Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Sproviero, W., Winchester, L., Newby, D., Fernandes, M., Shi, L., Goodday, S. M., et al. (2021). High Blood Pressure and Risk of Dementia: A Two-Sample Mendelian Randomization Study in the UK Biobank. Biological psychiatry. https://doi.org/10.1016/j.biopsych.2020.12.015
Vancouver
Sproviero W, Winchester L, Newby D, Fernandes M, Shi L, Goodday SM, et al. High Blood Pressure and Risk of Dementia: A Two-Sample Mendelian Randomization Study in the UK Biobank. Biological psychiatry. 2021. doi:10.1016/j.biopsych.2020.12.015. PMID: 33766239.
BibTeX
@article{sproviero2021-33766239,
author = {Sproviero, W. and Winchester, L. and Newby, D. and Fernandes, M. and Shi, L. and Goodday, S. M. and Prats-Uribe, A. and Alhambra, D. P. and others},
title = {{High Blood Pressure and Risk of Dementia: A Two-Sample Mendelian Randomization Study in the UK Biobank}},
journal = {Biological psychiatry},
year = {2021},
doi = {10.1016/j.biopsych.2020.12.015},
pmid = {33766239},
url = {https://doi.org/10.1016/j.biopsych.2020.12.015}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- We tested the hypothesis that a causal relationship exists between systolic BP (SBP) and/or diastolic BP (DBP) and risk of Alzheimer's disease (AD).
- Methods We performed a generalized summary Mendelian randomization (GSMR) analysis using summary statistics of a genome-wide association study meta-analysis of 299,024 individuals of SBP or DBP as exposure variables against three different outcomes: 1) AD diagnosis (International Genomics of Alzheimer's Project), 2) maternal family history of AD (UK Biobank), and 3) paternal family history of AD (UK Biobank).
- Finally, a combined meta-analysis of 368,440 individuals that included these three summary statistics was used as final outcome.
- Results GSMR applied to the International Genomics of Alzheimer's Project dataset revealed a significant effect of high SBP lowering the risk of AD (β GSMR = -0.19, p = .04).
Why it matters
This genetic analysis tested whether blood pressure has a causal relationship with Alzheimer's disease risk. It is a Mendelian randomization study and does not show that lowering blood pressure treats, cures, or prevents Alzheimer's disease.
Study details
- Study designmeta-analysis
- Participants299,024
- Evidence strengthHigh
How this study scored 68/100
Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. Scored zero for effect reported because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Biological psychiatry) |
| Journal's citation record | 3 / 4 | Biological Psychiatry: journal h-index 428 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 4 / 4 | 299,024 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 4 / 7 | Cited 85 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 12.1 citations a year over 7 year(s) since 2021 |
| Impact for its field and year | 3 / 6 | Cited 5.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 7 other studies in this library |
| Still being cited | 3 / 4 | Cited 51 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Alejo J. Nevado‐Holgado: h-index 38 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Oxford: institution h-index 2,205 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33766239) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 68 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.biopsych.2020.12.015
- PubMed: 33766239
- Original source →
- Free full text: Biological Psychiatry →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.
Later studies that cite this one
7 studies in the alzhub library list this one in their references.
Related studies in Long-term cohort studies from nearby years
Also tagged “obesity-hypertension-causal-dementia”
2 studies in the library carry the topic tag “obesity-hypertension-causal-dementia”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 2 tagged studies.